Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with ...
Principal of GMC Rajouri, Dr Amarjeet Singh Bhatia, told TNIE that the doctors at the hospital are now planning to reduce the Atropine doses for the patients. "All 11 patients undergoing treatment ...
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...
The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...